SSY Group Ltd., a pharmaceutical company based in Hong Kong, specializes in the research, development, manufacturing, and distribution of a diverse range of pharmaceutical products, including intravenous infusion solutions and ampoule injections. The company operates in two segments, focusing on intravenous infusion solutions and medical materials. With a risk rating score of 33.1, the company is categorized as high risk. SSY Group Ltd. generates the majority of its revenue from intravenous infusion solutions and pharmaceutical products, followed by medical materials.